Skip to main content

Month: April 2026

CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

Program provides access to leronlimab for patients with limited treatment options while supporting ongoing clinical development VANCOUVER, Washington, April 27, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (“mTNBC”) and colorectal cancer (“mCRC”), today announced the successful enrollment and initial dosing of the first participant in its Expanded Access Program (EAP) for patients with triple-negative breast cancer (TNBC). The EAP is designed to provide eligible patients access to leronlimab outside of a clinical study setting. The program...

Continue reading

March 2026 – Quarterly Activities Report

SYDNEY, April 27, 2026 (GLOBE NEWSWIRE) — Brazilian Rare Earths Limited (ASX: BRE) (OTCQX: BRELY / BRETF) is pleased to announce highlights for the quarter and subsequent period, including: MONTE ALTO EXPANDS WITH NEW ULTRA HIGH-GRADE DISCOVERIESDrilling continues to confirm Monte Alto as a globally significant ultra high-grade rare earth discovery, combining large-scale potential with exceptional grades and valuable critical mineral co-enrichment Drilling results included ultra high-grades of up to 35.3% TREO, with wide, continuous intercepts including 27.6 m at 19.4% TREO and 23.9 m at 17.4% TREO, and cumulative true thicknesses up to 43 metres with strong continuity Exceptional Rare Earth Enrichment: NdPr1 grades up to 59,645 ppm (5.96%) plus heavy rare earths DyTb2 up to 3,050 ppm and Y₂O₃ up to 10,975 ppm Critical mineral...

Continue reading

Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor

NEWTOWN, Pa., April 27, 2026 (GLOBE NEWSWIRE) — Solana Company (NASDAQ: HSDT) (“HSDT” or the “Company”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana tokens (“SOL”), today announced that it has entered into a definitive agreement providing for the purchase and sale of an aggregate of 3,076,922 shares of Class A common stock at a purchase price of $2.60 per share.   In addition, the Company entered into a put option agreement with the purchasers, pursuant to which the Company grants the purchasers the right, upon the occurrence of specified future events, to require the Company to repurchase all or a portion of the shares of Class A common stock it purchased in the registered direct offering at a price per share equal to the purchase price plus...

Continue reading

Cycurion Delivers on 2026 Profitable Growth Strategy with $6 Million Win and $112 Million Backlog Powered by Innovative AI Solutions

MCLEAN, Va., April 27, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a pioneering AI-driven cybersecurity and government technology solutions provider, today announced it has been awarded a $6 million purchase order under a Master Services Agreement (“MSA”) / Indefinite Delivery Indefinite Quantity (“IDIQ”) contract by a major U.S. municipality. The multi-year agreement allows Cycurion to provide a broad range of professional consulting services on an as-needed basis, including organization and management consulting, cybersecurity services, internal audit support, data analytics, and information technology solutions. The base contract term is three years, with two additional funded one-year option periods. “This contract award with a major municipality is another exciting win as we continue...

Continue reading

DeFi Development Corp. Announces Completion of April 2026 Community AMA

BOCA RATON, FL, April 27, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the successful completion of its March 2026 community Ask Me Anything (AMA) session hosted on Reddit. The AMA, held on April 24, 2026, provided an open forum for the Company’s management team to engage directly with its community and investors. Topics discussed included DFDV’s treasury strategy, Solana ecosystem developments, validator operations, digital asset treasury (DAT) expansion initiatives, and ongoing product innovation across its onchain yield and tokenization efforts. The AMA can be accessed here: https://www.reddit.com/r/DFDVDegens/comments/1sqvbjw/april_2026_official_dfdv_ama_ask_the_team_anything/. The...

Continue reading

Costamare Inc. Sets the Date for Its First Quarter 2026 Results Release, Conference Call and Webcast

Earnings Release: Wednesday, April 29, 2026, Before Market OpensConference Call and Webcast: Wednesday, April 29, 2026, at 8:30 a.m. ET MONACO, April 27, 2026 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE) (the “Company”), announced today that it will release its results for the first quarter ended March 31, 2026 before the market opens in New York on April 29, 2026. Conference Call Details: On Wednesday, April 29, 2026 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until May 6, 2026. The United States replay number...

Continue reading

Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress

Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and differentiated c-MET Inhibitor with best-in-class and first-in-class potential. To date, more than 600 patients and 170 healthy volunteers have been dosed with vebreltinib in clinical trials. Phase 2/3 IND submission for development of vebreltinib in combination with an EGFR inhibitor in the U.S. and select Asian countries for the treatment of NSCLC.FOSTER CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM), a clinical-stage biopharmaceutical company advancing innovative oncology therapies to transform the treatment landscape for patients with few or no options, today announced financial results for the full year ended December 31, 2025. “Our primary focus is to advance the global development of vebreltinib...

Continue reading

Skyline Bankshares, Inc. Announces First Quarter 2026 Results

FLOYD, Va. and INDEPENDENCE, Va., April 27, 2026 (GLOBE NEWSWIRE) — Skyline Bankshares, Inc. (the “Company”) (OTC QX: SLBK) – the holding company for Skyline National Bank (the “Bank”) – announced its results of operations for the first quarter of 2026.   The Company recorded net income of $4.6 million, or $0.82 per share, for the quarter ended March 31, 2026, compared to net income of $3.6 million, or $0.64 per share, for the same period in 2025.   First quarter 2026 earnings represented an annualized return on average assets (“ROAA”) of 1.43% and an annualized return on average equity (“ROAE”) of 16.84%, compared to 1.17% and 15.85%, respectively, for the same period last year. Net interest margin (“NIM”) was 4.55% for the first quarter of 2026, compared to 4.15% for the first quarter of 2025. President and CEO Blake Edwards stated,...

Continue reading

Franklin Electric Declares Quarterly Dividend of $0.28 Per Share

FORT WAYNE, Ind., April 27, 2026 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.28 per share payable May 21, 2026, to shareholders of record on May 7, 2026. About Franklin ElectricFranklin Electric is a global leader in the production and marketing of systems and components for the movement of water and energy. Recognized as a technical leader in its products and services, Franklin Electric serves customers worldwide in residential, commercial, agricultural, industrial, municipal, and fueling applications. Franklin Electric is proud to be recognized in Newsweek’s lists of America’s Most Responsible Companies 2025, Most Trustworthy Companies 2025, and Greenest Companies 2025. “Safe Harbor” Statement under the Private Securities Litigation...

Continue reading

First Atlantic Nickel Announces Name Change to First Atlantic Nickel & Cobalt Ahead of the Washington DC Safe Summit, Reinforcing the Natural Cobalt Content of Awaruite – a Rare, Naturally Magnetic (Ni-Fe-Co) Alloy That Is Sulfur-Free and Can Bypass Midstream Smelting Constraints in North America

GRAND FALLS-WINDSOR, Newfoundland and Labrador, April 27, 2026 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (TSXV: FAN | OTCQB: FANCF) (the “Company” or “First Atlantic”) is pleased to announce that it will change its name to First Atlantic Nickel & Cobalt Corp. (the “Name Change”), effective April 29, 2026, to reinforce the natural cobalt content of awaruite. Awaruite (Ni₃Fe) is a rare, naturally magnetic nickel-iron-cobalt (Ni-Fe-Co) alloy mineral with a high grade of nickel content. The Company’s Pipestone XL project in Newfoundland hosts broad zones of widely disseminated awaruite nickel and cobalt mineralization. The Company is also pleased to announce its participation at SAFE Summit 2026 in Washington, DC, taking place April 27-28, 2026, at the Walter E. Washington Convention...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.